Melanoma-or Something Else?

News
Article

This week’s quiz questions challenge you to determine the cause of an infant’s “strange breathing” based on a chest film, to come up with the most common cause of chronic cough in children, to be a dermatologic detective, among other things.

Question 1:

NEXT QUESTION »


For the discussion, click here.


For the answer, click here.


 

 

Question 2:

NEXT QUESTION »


For the discussion, click here.


For the answer, click here.


 

 

Question 3:

NEXT QUESTION »


For the discussion, click here.


For the answer, click here.


 

Question 4:

NEXT QUESTION »


For the discussion, click here.


For the answer, click here.


 

 

Question 5:

ANSWER KEY »


For the discussion, click here.


 

ANSWER KEY:

Question 1. B

Question 2. A

Question 3. D

Question 4. C

Question 5. C

Newsletter

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Subscribe Now!
Recent Videos
Primary Care is the Answer to the Migraine Care Gap, Says Headache Specialist
Migraine Management Pearls for Primary Care with Neurologist Jessica Ailani, MD
Migraine-specific therapies belong in primary care setting, Jessica Ailani, MD
Tezepelumab Significantly Reduced Exacerbations in Patients with Severe Asthma, Respiratory Comorbidities
Related Content
Digital Asthma Self Management Program Improves Symptom Control But Disparities in Benefit Are Clear / image credit Elevance Health

Digital Asthma Self Management Program Improves Symptom Control But Disparities in Benefit Are Clear

Grace Halsey
July 18th 2025
Article

A smartphone-based asthma management program significantly enhanced symptom control, but may require engagement or cultural tailoring to expand the effect.

The Weekly Dose: Clinical Updates on Cancer Detection, Cognitive Screening, CVD Prevention, Atopic Dermatitis Treatment

The Weekly Dose: Clinical Updates on Cancer Detection, Cognitive Screening, CVD Prevention, Atopic Dermatitis Treatment

Sydney Jennings
July 8th 2025
Podcast

Discover essential clinical insights on Alzheimer disease screening in primary care, eczema treatments, and the latest in cancer detection and diet impacts on CHD risk.

Dupilumab Sustains Long-Term Reduction of S. aureus in People with AD: Daily Dose / image credit: ©New Africa/AdobeStock

Dupilumab Sustains Long-Term Reduction of S. aureus in People with AD: Daily Dose

Sydney Jennings
July 16th 2025
Article

Your daily dose of the clinical news you may have missed.

Weekly Dose: A Roundup of Top Stories for Primary Care Physicians

Weekly Dose: A Roundup of Top Stories for Primary Care Physicians

Sydney Jennings
May 7th 2025
Podcast

PODCAST: Listen to our first episode for new research on bacterial vaginosis, a new treatment option for chronic urticaria, and more.

Upstream Bio's TSLP Antagonist Verekitug Enters Global Phase 2 Trial for COPD / image credit courtesy of Upstream Bio

Upstream Bio's TSLP Antagonist Verekitug Enters Global Phase 2 Trial for COPD

Grace Halsey
July 11th 2025
Article

Verekitug is the only biologic in development for COPD that targets the TSLP receptor directly.

Donanemab Label Revised: New Dosing Schedule Approved for Early Alzheimer’s Treatment

Donanemab Label Revised: New Dosing Schedule Approved for Early Alzheimer’s Treatment

Sydney Jennings
July 9th 2025
Article

The FDA approved updated dosing for donanemab in early Alzheimer disease, reducing ARIA-E risk by 41% without compromising efficacy.

© 2025 MJH Life Sciences

All rights reserved.